Expression of E-cadherin and α-, β-, γ-catenins in patients with bladder cancer -: Identification of γ-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors

被引:47
作者
Clairotte, A
Lascombe, I
Fauconnet, S
Mauny, F
Félix, S
Algros, MP
Bittard, H
Kantelip, B
机构
[1] Jean Minjoz Univ Hosp, Dept Pathol Cytol & Anat, Besancon, France
[2] Univ Franche Comte, Fac Med & Pharm, F-25030 Besancon, France
[3] St Jacques Univ Hosp, Dept Med Stat, Besancon, France
[4] St Jacques Univ Hosp, Dept Urol & Androl, Besancon, France
关键词
urothelial carcinoma; superficial bladder tumor; muscle-invasive bladder carcinoma; E-cadherin; alpha-catenin; beta-catenin; gamma-catenin; immunohistochemistry; prognostic marker;
D O I
10.1309/DKCLN4K2RK0V87YG
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Loss of intercellular adhesion facilitates tumor invasion. To clarify the relation between altered expression of cell adhesion molecules and progression. on of T1 supeificial bladder tumors, 101 cases (71 T1 tumors, 30 T2/T3 tumors) were examined immunohistochemically for E-cadherin and alpha-, beta-, and gamma-catenins. A highly significant correlation was observed between the decreased expression of all molecules and increased TNM stage (P < .001). Univariate analysis, petformed in cases of T1 tumors, revealed association of abnormal E-cadherin with beta-catenin diminution. Survival curves were established with. the Kaplan-Meier method and analyzed according to clinical and histopathologic parameters using the log-rank test. Cox multivariate analysis revealed only gamma-catenin as an independentpredictor of progression-free survival in patients with stage T1 bladder urothelial tumors. The characterization of T1 tumors that will progress could lead to the identification of patients who might benefit from surgery to avoid vesical muscle invasion and, consequently, metastasis.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 44 条
  • [1] Bane BL, 1996, SEMIN ONCOL, V23, P546
  • [2] BEHRENS J, 1994, INVAS METAST, V14, P61
  • [3] Billerey C, 2003, ANN PATHOL, V23, P21
  • [4] BRINGUIER PP, 1993, CANCER RES, V53, P3241
  • [5] Bringuier PP, 1999, INT J CANCER, V83, P591, DOI 10.1002/(SICI)1097-0215(19991126)83:5<591::AID-IJC3>3.0.CO
  • [6] 2-6
  • [7] Bull K, 1997, STAT MED, V16, P1041
  • [8] E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup
    Byrne, RA
    Shariat, SF
    Brown, R
    Kattan, MW
    Morton, RA
    Wheeler, TM
    Lerner, SP
    [J]. JOURNAL OF UROLOGY, 2001, 165 (05) : 1473 - 1479
  • [9] The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
    Cano, A
    Pérez-Moreno, MA
    Rodrigo, I
    Locascio, A
    Blanco, MJ
    del Barrio, MG
    Portillo, F
    Nieto, MA
    [J]. NATURE CELL BIOLOGY, 2000, 2 (02) : 76 - 83
  • [10] Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
    Cavallaro, U
    Christofori, G
    [J]. NATURE REVIEWS CANCER, 2004, 4 (02) : 118 - 132